| Gps Guide To Personal Solutions | |
|
1801 E Saginaw St Ste 1 Lansing MI 48912-2326 | |
| (517) 667-0061 | |
| (517) 507-4888 |
| Full Name | Gps Guide To Personal Solutions |
|---|---|
| Speciality | Community/Behavioral Health |
| Location | 1801 E Saginaw St Ste 1, Lansing, Michigan |
| Authorized Official Name and Position | Nicole Cheri Dingwell (DIRECTOR) |
| Authorized Official Contact | 5176670061 |
| Accepts Medicare Insurance | Yes. This clinic participates in medicare program and accept medicare insurance. |
| Mailing Address | Practice Location Address |
|---|---|
| Gps Guide To Personal Solutions 1801 E Saginaw St Ste 1 Lansing MI 48912-2326 Ph: (517) 667-0061 | Gps Guide To Personal Solutions 1801 E Saginaw St Ste 1 Lansing MI 48912-2326 Ph: (517) 667-0061 |
| NPI Number | 1114367380 |
|---|---|
| Provider Enumeration Date | 07/02/2013 |
| Last Update Date | 10/24/2023 |
| Certification Date | 10/24/2023 |
| Medicare PECOS PAC ID | 4385864768 |
|---|---|
| Medicare Enrollment ID | O20141007001183 |
News Archive
Widespread use of a new fast-acting and potent treatment for malaria is finally on the horizon in Africa, where malaria is the number one killer of children.
Roche and study investigators from Harvard University and Massachusetts General Hospital announced today that in the PROTECT (Pro-BNP Outpatient Tailored Chronic HF Therapy) trial, a strategy of NT-proBNP guided heart failure care was independently associated with a significant reduction in total cardiovascular events, the primary composite endpoint of the study, which included worsening heart failure, heart failure hospitalization and cardiovascular related death
Press Ganey Associates announces the formation of a new strategic consulting group to help further client improvement efforts. The Press Ganey Consulting Group, which consists of experts including former hospital administrators and medical staff, offers a unique perspective on the industry.
Karo Bio AB has entered into a research collaboration agreement with Pfizer Inc., to discover and develop novel small molecule RORgamma modulators for the treatment of autoimmune diseases.
› Verified 2 days ago
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114367380 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 251S00000X | Community/behavioral Health | 6801092564 (Michigan) | Primary |
| Provider Name | Ronald B Penfield |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1023161064 PECOS PAC ID: 9830290782 Enrollment ID: I20070723000671 |
News Archive
Widespread use of a new fast-acting and potent treatment for malaria is finally on the horizon in Africa, where malaria is the number one killer of children.
Roche and study investigators from Harvard University and Massachusetts General Hospital announced today that in the PROTECT (Pro-BNP Outpatient Tailored Chronic HF Therapy) trial, a strategy of NT-proBNP guided heart failure care was independently associated with a significant reduction in total cardiovascular events, the primary composite endpoint of the study, which included worsening heart failure, heart failure hospitalization and cardiovascular related death
Press Ganey Associates announces the formation of a new strategic consulting group to help further client improvement efforts. The Press Ganey Consulting Group, which consists of experts including former hospital administrators and medical staff, offers a unique perspective on the industry.
Karo Bio AB has entered into a research collaboration agreement with Pfizer Inc., to discover and develop novel small molecule RORgamma modulators for the treatment of autoimmune diseases.
› Verified 2 days ago
| Provider Name | Alice S Williams |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1710063847 PECOS PAC ID: 1557546736 Enrollment ID: I20110503000797 |
News Archive
Widespread use of a new fast-acting and potent treatment for malaria is finally on the horizon in Africa, where malaria is the number one killer of children.
Roche and study investigators from Harvard University and Massachusetts General Hospital announced today that in the PROTECT (Pro-BNP Outpatient Tailored Chronic HF Therapy) trial, a strategy of NT-proBNP guided heart failure care was independently associated with a significant reduction in total cardiovascular events, the primary composite endpoint of the study, which included worsening heart failure, heart failure hospitalization and cardiovascular related death
Press Ganey Associates announces the formation of a new strategic consulting group to help further client improvement efforts. The Press Ganey Consulting Group, which consists of experts including former hospital administrators and medical staff, offers a unique perspective on the industry.
Karo Bio AB has entered into a research collaboration agreement with Pfizer Inc., to discover and develop novel small molecule RORgamma modulators for the treatment of autoimmune diseases.
› Verified 2 days ago
| Provider Name | Nicole Cheri Dingwell Frendt |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1851691620 PECOS PAC ID: 8628222528 Enrollment ID: I20130130000242 |
News Archive
Widespread use of a new fast-acting and potent treatment for malaria is finally on the horizon in Africa, where malaria is the number one killer of children.
Roche and study investigators from Harvard University and Massachusetts General Hospital announced today that in the PROTECT (Pro-BNP Outpatient Tailored Chronic HF Therapy) trial, a strategy of NT-proBNP guided heart failure care was independently associated with a significant reduction in total cardiovascular events, the primary composite endpoint of the study, which included worsening heart failure, heart failure hospitalization and cardiovascular related death
Press Ganey Associates announces the formation of a new strategic consulting group to help further client improvement efforts. The Press Ganey Consulting Group, which consists of experts including former hospital administrators and medical staff, offers a unique perspective on the industry.
Karo Bio AB has entered into a research collaboration agreement with Pfizer Inc., to discover and develop novel small molecule RORgamma modulators for the treatment of autoimmune diseases.
› Verified 2 days ago
| Provider Name | David Earl Ware |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1114990801 PECOS PAC ID: 6800106907 Enrollment ID: I20151102001034 |
News Archive
Widespread use of a new fast-acting and potent treatment for malaria is finally on the horizon in Africa, where malaria is the number one killer of children.
Roche and study investigators from Harvard University and Massachusetts General Hospital announced today that in the PROTECT (Pro-BNP Outpatient Tailored Chronic HF Therapy) trial, a strategy of NT-proBNP guided heart failure care was independently associated with a significant reduction in total cardiovascular events, the primary composite endpoint of the study, which included worsening heart failure, heart failure hospitalization and cardiovascular related death
Press Ganey Associates announces the formation of a new strategic consulting group to help further client improvement efforts. The Press Ganey Consulting Group, which consists of experts including former hospital administrators and medical staff, offers a unique perspective on the industry.
Karo Bio AB has entered into a research collaboration agreement with Pfizer Inc., to discover and develop novel small molecule RORgamma modulators for the treatment of autoimmune diseases.
› Verified 2 days ago
| Provider Name | Heather R Roberts |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1609307800 PECOS PAC ID: 6002192176 Enrollment ID: I20170405000150 |
News Archive
Widespread use of a new fast-acting and potent treatment for malaria is finally on the horizon in Africa, where malaria is the number one killer of children.
Roche and study investigators from Harvard University and Massachusetts General Hospital announced today that in the PROTECT (Pro-BNP Outpatient Tailored Chronic HF Therapy) trial, a strategy of NT-proBNP guided heart failure care was independently associated with a significant reduction in total cardiovascular events, the primary composite endpoint of the study, which included worsening heart failure, heart failure hospitalization and cardiovascular related death
Press Ganey Associates announces the formation of a new strategic consulting group to help further client improvement efforts. The Press Ganey Consulting Group, which consists of experts including former hospital administrators and medical staff, offers a unique perspective on the industry.
Karo Bio AB has entered into a research collaboration agreement with Pfizer Inc., to discover and develop novel small molecule RORgamma modulators for the treatment of autoimmune diseases.
› Verified 2 days ago
| Provider Name | Stephanie Gonzalez |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1770987083 PECOS PAC ID: 2264706258 Enrollment ID: I20170914000255 |
News Archive
Widespread use of a new fast-acting and potent treatment for malaria is finally on the horizon in Africa, where malaria is the number one killer of children.
Roche and study investigators from Harvard University and Massachusetts General Hospital announced today that in the PROTECT (Pro-BNP Outpatient Tailored Chronic HF Therapy) trial, a strategy of NT-proBNP guided heart failure care was independently associated with a significant reduction in total cardiovascular events, the primary composite endpoint of the study, which included worsening heart failure, heart failure hospitalization and cardiovascular related death
Press Ganey Associates announces the formation of a new strategic consulting group to help further client improvement efforts. The Press Ganey Consulting Group, which consists of experts including former hospital administrators and medical staff, offers a unique perspective on the industry.
Karo Bio AB has entered into a research collaboration agreement with Pfizer Inc., to discover and develop novel small molecule RORgamma modulators for the treatment of autoimmune diseases.
› Verified 2 days ago
| Provider Name | Jose Carrera |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1275983280 PECOS PAC ID: 2668730425 Enrollment ID: I20171227002492 |
News Archive
Widespread use of a new fast-acting and potent treatment for malaria is finally on the horizon in Africa, where malaria is the number one killer of children.
Roche and study investigators from Harvard University and Massachusetts General Hospital announced today that in the PROTECT (Pro-BNP Outpatient Tailored Chronic HF Therapy) trial, a strategy of NT-proBNP guided heart failure care was independently associated with a significant reduction in total cardiovascular events, the primary composite endpoint of the study, which included worsening heart failure, heart failure hospitalization and cardiovascular related death
Press Ganey Associates announces the formation of a new strategic consulting group to help further client improvement efforts. The Press Ganey Consulting Group, which consists of experts including former hospital administrators and medical staff, offers a unique perspective on the industry.
Karo Bio AB has entered into a research collaboration agreement with Pfizer Inc., to discover and develop novel small molecule RORgamma modulators for the treatment of autoimmune diseases.
› Verified 2 days ago
| Provider Name | Priscilla C Cortez |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1700271574 PECOS PAC ID: 3971858812 Enrollment ID: I20180619000088 |
News Archive
Widespread use of a new fast-acting and potent treatment for malaria is finally on the horizon in Africa, where malaria is the number one killer of children.
Roche and study investigators from Harvard University and Massachusetts General Hospital announced today that in the PROTECT (Pro-BNP Outpatient Tailored Chronic HF Therapy) trial, a strategy of NT-proBNP guided heart failure care was independently associated with a significant reduction in total cardiovascular events, the primary composite endpoint of the study, which included worsening heart failure, heart failure hospitalization and cardiovascular related death
Press Ganey Associates announces the formation of a new strategic consulting group to help further client improvement efforts. The Press Ganey Consulting Group, which consists of experts including former hospital administrators and medical staff, offers a unique perspective on the industry.
Karo Bio AB has entered into a research collaboration agreement with Pfizer Inc., to discover and develop novel small molecule RORgamma modulators for the treatment of autoimmune diseases.
› Verified 2 days ago
| Provider Name | Edith Root-clark |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1689827768 PECOS PAC ID: 2365863685 Enrollment ID: I20200521003018 |
News Archive
Widespread use of a new fast-acting and potent treatment for malaria is finally on the horizon in Africa, where malaria is the number one killer of children.
Roche and study investigators from Harvard University and Massachusetts General Hospital announced today that in the PROTECT (Pro-BNP Outpatient Tailored Chronic HF Therapy) trial, a strategy of NT-proBNP guided heart failure care was independently associated with a significant reduction in total cardiovascular events, the primary composite endpoint of the study, which included worsening heart failure, heart failure hospitalization and cardiovascular related death
Press Ganey Associates announces the formation of a new strategic consulting group to help further client improvement efforts. The Press Ganey Consulting Group, which consists of experts including former hospital administrators and medical staff, offers a unique perspective on the industry.
Karo Bio AB has entered into a research collaboration agreement with Pfizer Inc., to discover and develop novel small molecule RORgamma modulators for the treatment of autoimmune diseases.
› Verified 2 days ago
| Provider Name | Lara Pomnitz |
|---|---|
| Provider Type | Practitioner - Clinical Social Worker |
| Provider Identifiers | NPI Number: 1568955128 PECOS PAC ID: 0749680809 Enrollment ID: I20210610001537 |
News Archive
Widespread use of a new fast-acting and potent treatment for malaria is finally on the horizon in Africa, where malaria is the number one killer of children.
Roche and study investigators from Harvard University and Massachusetts General Hospital announced today that in the PROTECT (Pro-BNP Outpatient Tailored Chronic HF Therapy) trial, a strategy of NT-proBNP guided heart failure care was independently associated with a significant reduction in total cardiovascular events, the primary composite endpoint of the study, which included worsening heart failure, heart failure hospitalization and cardiovascular related death
Press Ganey Associates announces the formation of a new strategic consulting group to help further client improvement efforts. The Press Ganey Consulting Group, which consists of experts including former hospital administrators and medical staff, offers a unique perspective on the industry.
Karo Bio AB has entered into a research collaboration agreement with Pfizer Inc., to discover and develop novel small molecule RORgamma modulators for the treatment of autoimmune diseases.
› Verified 2 days ago
| Provider Name | Richard S Wampler |
|---|---|
| Provider Type | Practitioner - Clinical Psychologist |
| Provider Identifiers | NPI Number: 1699983098 PECOS PAC ID: 0648643890 Enrollment ID: I20230308002983 |
News Archive
Widespread use of a new fast-acting and potent treatment for malaria is finally on the horizon in Africa, where malaria is the number one killer of children.
Roche and study investigators from Harvard University and Massachusetts General Hospital announced today that in the PROTECT (Pro-BNP Outpatient Tailored Chronic HF Therapy) trial, a strategy of NT-proBNP guided heart failure care was independently associated with a significant reduction in total cardiovascular events, the primary composite endpoint of the study, which included worsening heart failure, heart failure hospitalization and cardiovascular related death
Press Ganey Associates announces the formation of a new strategic consulting group to help further client improvement efforts. The Press Ganey Consulting Group, which consists of experts including former hospital administrators and medical staff, offers a unique perspective on the industry.
Karo Bio AB has entered into a research collaboration agreement with Pfizer Inc., to discover and develop novel small molecule RORgamma modulators for the treatment of autoimmune diseases.
› Verified 2 days ago
| Provider Name | Jacqueline Nicole White |
|---|---|
| Provider Type | Practitioner - Mental Health Counselor |
| Provider Identifiers | NPI Number: 1710479431 PECOS PAC ID: 5698127553 Enrollment ID: I20240117001065 |
News Archive
Widespread use of a new fast-acting and potent treatment for malaria is finally on the horizon in Africa, where malaria is the number one killer of children.
Roche and study investigators from Harvard University and Massachusetts General Hospital announced today that in the PROTECT (Pro-BNP Outpatient Tailored Chronic HF Therapy) trial, a strategy of NT-proBNP guided heart failure care was independently associated with a significant reduction in total cardiovascular events, the primary composite endpoint of the study, which included worsening heart failure, heart failure hospitalization and cardiovascular related death
Press Ganey Associates announces the formation of a new strategic consulting group to help further client improvement efforts. The Press Ganey Consulting Group, which consists of experts including former hospital administrators and medical staff, offers a unique perspective on the industry.
Karo Bio AB has entered into a research collaboration agreement with Pfizer Inc., to discover and develop novel small molecule RORgamma modulators for the treatment of autoimmune diseases.
› Verified 2 days ago
News Archive
Widespread use of a new fast-acting and potent treatment for malaria is finally on the horizon in Africa, where malaria is the number one killer of children.
Roche and study investigators from Harvard University and Massachusetts General Hospital announced today that in the PROTECT (Pro-BNP Outpatient Tailored Chronic HF Therapy) trial, a strategy of NT-proBNP guided heart failure care was independently associated with a significant reduction in total cardiovascular events, the primary composite endpoint of the study, which included worsening heart failure, heart failure hospitalization and cardiovascular related death
Press Ganey Associates announces the formation of a new strategic consulting group to help further client improvement efforts. The Press Ganey Consulting Group, which consists of experts including former hospital administrators and medical staff, offers a unique perspective on the industry.
Karo Bio AB has entered into a research collaboration agreement with Pfizer Inc., to discover and develop novel small molecule RORgamma modulators for the treatment of autoimmune diseases.
› Verified 2 days ago
Jonathon Novello Lmsw Acsw Pllc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2535 E Mount Hope Ave, Lansing, MI 48910 Phone: 517-290-7011 | |
Quiet Sky Counseling Llc Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 2535 E Mount Hope Ave, Lansing, MI 48910 Phone: 989-214-4238 | |
Chance Happens Counseling Center Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 15831 Brook Rd, Lansing, MI 48906 Phone: 309-648-1720 | |
Sparrow Behavioral Health - Social Workers Mental Health Clinic Medicare: Medicare Enrolled Practice Location: 1210 W Saginaw St, 2nd Floor, Lansing, MI 48915 Phone: 517-364-7700 Fax: 517-364-7701 | |
Psychological Associates In Rehabilitation Pc Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 3960 Patient Care Way, Suite 104, Lansing, MI 48911 Phone: 517-887-9801 Fax: 517-887-9826 | |
Ira Zachary Dyme Md Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 2909 E Grand Riv, Suite 108, Lansing, MI 48912 Phone: 517-482-1111 Fax: 517-482-1119 | |
Holistic Vida Therapy Mental Health Clinic Medicare: Not Enrolled in Medicare Practice Location: 119 Pere Marquette Dr Ste 2d, Lansing, MI 48912 Phone: 517-455-7555 |